nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Dactinomycin—skin cancer	0.456	1	CbGbCtD
Cefadroxil—Genital candidiasis—Imiquimod—skin cancer	0.0322	0.0593	CcSEcCtD
Cefadroxil—Superinfection—Fluorouracil—skin cancer	0.0171	0.0315	CcSEcCtD
Cefadroxil—Infertility—Temozolomide—skin cancer	0.0162	0.0297	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Vismodegib—skin cancer	0.0134	0.0246	CcSEcCtD
Cefadroxil—Blood urea increased—Vismodegib—skin cancer	0.0126	0.0232	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.0112	0.0205	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00873	0.0161	CcSEcCtD
Cefadroxil—Nephropathy toxic—Bleomycin—skin cancer	0.00871	0.016	CcSEcCtD
Cefadroxil—Vaginal inflammation—Imiquimod—skin cancer	0.00704	0.0129	CcSEcCtD
Cefadroxil—Vaginal infection—Imiquimod—skin cancer	0.00665	0.0122	CcSEcCtD
Cefadroxil—Digestion impaired—Temozolomide—skin cancer	0.00631	0.0116	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Imiquimod—skin cancer	0.00585	0.0107	CcSEcCtD
Cefadroxil—Swelling—Imiquimod—skin cancer	0.00579	0.0106	CcSEcCtD
Cefadroxil—Muscle spasms—Vismodegib—skin cancer	0.00562	0.0103	CcSEcCtD
Cefadroxil—Cholestasis—Temozolomide—skin cancer	0.00556	0.0102	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.0054	0.00992	CcSEcCtD
Cefadroxil—Eosinophilia—Vemurafenib—skin cancer	0.00513	0.00943	CcSEcCtD
Cefadroxil—Arthralgia—Vismodegib—skin cancer	0.00497	0.00914	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00458	0.00842	CcSEcCtD
Cefadroxil—Aplastic anaemia—Dactinomycin—skin cancer	0.00438	0.00805	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00434	0.00798	CcSEcCtD
Cefadroxil—Vaginal inflammation—Temozolomide—skin cancer	0.00422	0.00776	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Temozolomide—skin cancer	0.00422	0.00776	CcSEcCtD
Cefadroxil—Dyspepsia—Vismodegib—skin cancer	0.0042	0.00771	CcSEcCtD
Cefadroxil—Pancytopenia—Imiquimod—skin cancer	0.00419	0.00771	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vismodegib—skin cancer	0.00412	0.00757	CcSEcCtD
Cefadroxil—Vaginal infection—Temozolomide—skin cancer	0.00398	0.00732	CcSEcCtD
Cefadroxil—Aplastic anaemia—Temozolomide—skin cancer	0.00396	0.00728	CcSEcCtD
Cefadroxil—Erythema multiforme—Vemurafenib—skin cancer	0.00392	0.0072	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.0039	0.00718	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vismodegib—skin cancer	0.0039	0.00717	CcSEcCtD
Cefadroxil—Abdominal pain—Vismodegib—skin cancer	0.00377	0.00693	CcSEcCtD
Cefadroxil—Hepatic failure—Dactinomycin—skin cancer	0.00377	0.00693	CcSEcCtD
Cefadroxil—Haemoglobin—Imiquimod—skin cancer	0.00355	0.00653	CcSEcCtD
Cefadroxil—Haemorrhage—Imiquimod—skin cancer	0.00354	0.0065	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.00352	0.00647	CcSEcCtD
Cefadroxil—Asthenia—Vismodegib—skin cancer	0.00342	0.00629	CcSEcCtD
Cefadroxil—Hepatic failure—Temozolomide—skin cancer	0.00341	0.00626	CcSEcCtD
Cefadroxil—Pruritus—Vismodegib—skin cancer	0.00337	0.0062	CcSEcCtD
Cefadroxil—Erythema multiforme—Imiquimod—skin cancer	0.00334	0.00614	CcSEcCtD
Cefadroxil—Diarrhoea—Vismodegib—skin cancer	0.00326	0.006	CcSEcCtD
Cefadroxil—Swelling—Fluorouracil—skin cancer	0.0032	0.00588	CcSEcCtD
Cefadroxil—Arthralgia—Vemurafenib—skin cancer	0.00307	0.00565	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00305	0.0056	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00305	0.0056	CcSEcCtD
Cefadroxil—Vomiting—Vismodegib—skin cancer	0.00303	0.00557	CcSEcCtD
Cefadroxil—Rash—Vismodegib—skin cancer	0.00301	0.00553	CcSEcCtD
Cefadroxil—Dermatitis—Vismodegib—skin cancer	0.003	0.00552	CcSEcCtD
Cefadroxil—Pancytopenia—Bleomycin—skin cancer	0.00298	0.00548	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Docetaxel—skin cancer	0.00297	0.00545	CcSEcCtD
Cefadroxil—Anaphylactic shock—Vemurafenib—skin cancer	0.00295	0.00541	CcSEcCtD
Cefadroxil—Nausea—Vismodegib—skin cancer	0.00283	0.00521	CcSEcCtD
Cefadroxil—Angioedema—Imiquimod—skin cancer	0.00281	0.00517	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Docetaxel—skin cancer	0.00281	0.00516	CcSEcCtD
Cefadroxil—Pancytopenia—Dactinomycin—skin cancer	0.00278	0.00511	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00276	0.00507	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00276	0.00507	CcSEcCtD
Cefadroxil—Neutropenia—Dactinomycin—skin cancer	0.00274	0.00503	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Temozolomide—skin cancer	0.0027	0.00496	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00268	0.00493	CcSEcCtD
Cefadroxil—Convulsion—Imiquimod—skin cancer	0.00267	0.0049	CcSEcCtD
Cefadroxil—Arthralgia—Imiquimod—skin cancer	0.00262	0.00482	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00259	0.00476	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00254	0.00467	CcSEcCtD
Cefadroxil—Haemoglobin—Bleomycin—skin cancer	0.00252	0.00464	CcSEcCtD
Cefadroxil—Pancytopenia—Temozolomide—skin cancer	0.00251	0.00462	CcSEcCtD
Cefadroxil—Haemorrhage—Bleomycin—skin cancer	0.00251	0.00462	CcSEcCtD
Cefadroxil—Neutropenia—Temozolomide—skin cancer	0.00248	0.00455	CcSEcCtD
Cefadroxil—Agranulocytosis—Dactinomycin—skin cancer	0.00243	0.00448	CcSEcCtD
Cefadroxil—Eosinophilia—Fluorouracil—skin cancer	0.00241	0.00444	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00234	0.0043	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00234	0.0043	CcSEcCtD
Cefadroxil—Body temperature increased—Vemurafenib—skin cancer	0.00233	0.00428	CcSEcCtD
Cefadroxil—Pancytopenia—Fluorouracil—skin cancer	0.00232	0.00426	CcSEcCtD
Cefadroxil—Swelling—Docetaxel—skin cancer	0.00231	0.00424	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00229	0.00421	CcSEcCtD
Cefadroxil—Hepatic failure—Docetaxel—skin cancer	0.00227	0.00417	CcSEcCtD
Cefadroxil—Somnolence—Imiquimod—skin cancer	0.00223	0.0041	CcSEcCtD
Cefadroxil—Erythema multiforme—Dactinomycin—skin cancer	0.00221	0.00407	CcSEcCtD
Cefadroxil—Dyspepsia—Imiquimod—skin cancer	0.00221	0.00406	CcSEcCtD
Cefadroxil—Hypersensitivity—Vemurafenib—skin cancer	0.00217	0.00399	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Imiquimod—skin cancer	0.00217	0.00399	CcSEcCtD
Cefadroxil—Haemoglobin—Temozolomide—skin cancer	0.00213	0.00391	CcSEcCtD
Cefadroxil—Haemorrhage—Temozolomide—skin cancer	0.00212	0.00389	CcSEcCtD
Cefadroxil—Asthenia—Vemurafenib—skin cancer	0.00211	0.00388	CcSEcCtD
Cefadroxil—Pruritus—Vemurafenib—skin cancer	0.00208	0.00383	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Imiquimod—skin cancer	0.00205	0.00378	CcSEcCtD
Cefadroxil—Agranulocytosis—Fluorouracil—skin cancer	0.00203	0.00373	CcSEcCtD
Cefadroxil—Diarrhoea—Vemurafenib—skin cancer	0.00202	0.0037	CcSEcCtD
Cefadroxil—Erythema multiforme—Temozolomide—skin cancer	0.002	0.00368	CcSEcCtD
Cefadroxil—Urticaria—Imiquimod—skin cancer	0.002	0.00367	CcSEcCtD
Cefadroxil—Abdominal pain—Imiquimod—skin cancer	0.00199	0.00365	CcSEcCtD
Cefadroxil—Body temperature increased—Imiquimod—skin cancer	0.00199	0.00365	CcSEcCtD
Cefadroxil—Haemoglobin—Fluorouracil—skin cancer	0.00196	0.00361	CcSEcCtD
Cefadroxil—Haemorrhage—Fluorouracil—skin cancer	0.00195	0.00359	CcSEcCtD
Cefadroxil—Dizziness—Vemurafenib—skin cancer	0.00195	0.00358	CcSEcCtD
Cefadroxil—Vomiting—Vemurafenib—skin cancer	0.00187	0.00344	CcSEcCtD
Cefadroxil—Rash—Vemurafenib—skin cancer	0.00186	0.00341	CcSEcCtD
Cefadroxil—Dermatitis—Vemurafenib—skin cancer	0.00186	0.00341	CcSEcCtD
Cefadroxil—Hypersensitivity—Imiquimod—skin cancer	0.00185	0.0034	CcSEcCtD
Cefadroxil—Headache—Vemurafenib—skin cancer	0.00185	0.00339	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00183	0.00337	CcSEcCtD
Cefadroxil—Cramp muscle—Docetaxel—skin cancer	0.00183	0.00337	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00183	0.00337	CcSEcCtD
Cefadroxil—Asthenia—Imiquimod—skin cancer	0.0018	0.00331	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Docetaxel—skin cancer	0.0018	0.0033	CcSEcCtD
Cefadroxil—Anaphylactic shock—Bleomycin—skin cancer	0.00178	0.00328	CcSEcCtD
Cefadroxil—Pruritus—Imiquimod—skin cancer	0.00178	0.00327	CcSEcCtD
Cefadroxil—Nausea—Vemurafenib—skin cancer	0.00175	0.00322	CcSEcCtD
Cefadroxil—Thrombocytopenia—Bleomycin—skin cancer	0.00175	0.00321	CcSEcCtD
Cefadroxil—Diarrhoea—Imiquimod—skin cancer	0.00172	0.00316	CcSEcCtD
Cefadroxil—Angioedema—Temozolomide—skin cancer	0.00169	0.0031	CcSEcCtD
Cefadroxil—Pancytopenia—Docetaxel—skin cancer	0.00167	0.00307	CcSEcCtD
Cefadroxil—Dizziness—Imiquimod—skin cancer	0.00166	0.00305	CcSEcCtD
Cefadroxil—Vertigo—Temozolomide—skin cancer	0.00166	0.00305	CcSEcCtD
Cefadroxil—Neutropenia—Docetaxel—skin cancer	0.00165	0.00303	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—skin cancer	0.00163	0.003	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00163	0.00299	CcSEcCtD
Cefadroxil—Convulsion—Temozolomide—skin cancer	0.0016	0.00294	CcSEcCtD
Cefadroxil—Vomiting—Imiquimod—skin cancer	0.0016	0.00294	CcSEcCtD
Cefadroxil—Rash—Imiquimod—skin cancer	0.00158	0.00291	CcSEcCtD
Cefadroxil—Dermatitis—Imiquimod—skin cancer	0.00158	0.00291	CcSEcCtD
Cefadroxil—Headache—Imiquimod—skin cancer	0.00157	0.00289	CcSEcCtD
Cefadroxil—Arthralgia—Temozolomide—skin cancer	0.00157	0.00289	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00156	0.00286	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00152	0.00279	CcSEcCtD
Cefadroxil—Anaphylactic shock—Temozolomide—skin cancer	0.00151	0.00277	CcSEcCtD
Cefadroxil—Nausea—Imiquimod—skin cancer	0.00149	0.00274	CcSEcCtD
Cefadroxil—Thrombocytopenia—Temozolomide—skin cancer	0.00147	0.00271	CcSEcCtD
Cefadroxil—Convulsion—Fluorouracil—skin cancer	0.00147	0.00271	CcSEcCtD
Cefadroxil—Agranulocytosis—Docetaxel—skin cancer	0.00146	0.00269	CcSEcCtD
Cefadroxil—Urticaria—Bleomycin—skin cancer	0.00142	0.00261	CcSEcCtD
Cefadroxil—Haemoglobin—Docetaxel—skin cancer	0.00142	0.0026	CcSEcCtD
Cefadroxil—Body temperature increased—Bleomycin—skin cancer	0.00141	0.00259	CcSEcCtD
Cefadroxil—Haemorrhage—Docetaxel—skin cancer	0.00141	0.00259	CcSEcCtD
Cefadroxil—Anaphylactic shock—Fluorouracil—skin cancer	0.00139	0.00255	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00137	0.00252	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dactinomycin—skin cancer	0.00136	0.0025	CcSEcCtD
Cefadroxil—Thrombocytopenia—Fluorouracil—skin cancer	0.00136	0.0025	CcSEcCtD
Cefadroxil—Somnolence—Temozolomide—skin cancer	0.00134	0.00246	CcSEcCtD
Cefadroxil—Erythema multiforme—Docetaxel—skin cancer	0.00133	0.00245	CcSEcCtD
Cefadroxil—Dyspepsia—Temozolomide—skin cancer	0.00132	0.00244	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—skin cancer	0.00132	0.00242	CcSEcCtD
Cefadroxil—Abdominal pain—Dactinomycin—skin cancer	0.00132	0.00242	CcSEcCtD
Cefadroxil—Hypersensitivity—Bleomycin—skin cancer	0.00131	0.00242	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Temozolomide—skin cancer	0.0013	0.00239	CcSEcCtD
Cefadroxil—Asthenia—Bleomycin—skin cancer	0.00128	0.00235	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00126	0.00232	CcSEcCtD
Cefadroxil—Pruritus—Bleomycin—skin cancer	0.00126	0.00232	CcSEcCtD
Cefadroxil—Somnolence—Fluorouracil—skin cancer	0.00123	0.00227	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Temozolomide—skin cancer	0.00123	0.00226	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—skin cancer	0.00123	0.00225	CcSEcCtD
Cefadroxil—Dyspepsia—Fluorouracil—skin cancer	0.00122	0.00224	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Fluorouracil—skin cancer	0.0012	0.0022	CcSEcCtD
Cefadroxil—Urticaria—Temozolomide—skin cancer	0.0012	0.0022	CcSEcCtD
Cefadroxil—Asthenia—Dactinomycin—skin cancer	0.00119	0.00219	CcSEcCtD
Cefadroxil—Abdominal pain—Temozolomide—skin cancer	0.00119	0.00219	CcSEcCtD
Cefadroxil—Body temperature increased—Temozolomide—skin cancer	0.00119	0.00219	CcSEcCtD
Cefadroxil—Muscle spasms—Docetaxel—skin cancer	0.00118	0.00217	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—skin cancer	0.00114	0.00209	CcSEcCtD
Cefadroxil—Vomiting—Bleomycin—skin cancer	0.00113	0.00209	CcSEcCtD
Cefadroxil—Rash—Bleomycin—skin cancer	0.00113	0.00207	CcSEcCtD
Cefadroxil—Dermatitis—Bleomycin—skin cancer	0.00112	0.00207	CcSEcCtD
Cefadroxil—Hypersensitivity—Temozolomide—skin cancer	0.00111	0.00204	CcSEcCtD
Cefadroxil—Urticaria—Fluorouracil—skin cancer	0.0011	0.00203	CcSEcCtD
Cefadroxil—Body temperature increased—Fluorouracil—skin cancer	0.0011	0.00202	CcSEcCtD
Cefadroxil—Asthenia—Temozolomide—skin cancer	0.00108	0.00199	CcSEcCtD
Cefadroxil—Pruritus—Temozolomide—skin cancer	0.00106	0.00196	CcSEcCtD
Cefadroxil—Convulsion—Docetaxel—skin cancer	0.00106	0.00195	CcSEcCtD
Cefadroxil—Nausea—Bleomycin—skin cancer	0.00106	0.00195	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—skin cancer	0.00106	0.00194	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—skin cancer	0.00105	0.00193	CcSEcCtD
Cefadroxil—Arthralgia—Docetaxel—skin cancer	0.00104	0.00192	CcSEcCtD
Cefadroxil—Diarrhoea—Temozolomide—skin cancer	0.00103	0.00189	CcSEcCtD
Cefadroxil—Hypersensitivity—Fluorouracil—skin cancer	0.00102	0.00188	CcSEcCtD
Cefadroxil—Anaphylactic shock—Docetaxel—skin cancer	0.001	0.00184	CcSEcCtD
Cefadroxil—Dizziness—Temozolomide—skin cancer	0.000995	0.00183	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—skin cancer	0.000988	0.00182	CcSEcCtD
Cefadroxil—Pruritus—Fluorouracil—skin cancer	0.000981	0.0018	CcSEcCtD
Cefadroxil—Thrombocytopenia—Docetaxel—skin cancer	0.00098	0.0018	CcSEcCtD
Cefadroxil—Vomiting—Temozolomide—skin cancer	0.000957	0.00176	CcSEcCtD
Cefadroxil—Rash—Temozolomide—skin cancer	0.000949	0.00174	CcSEcCtD
Cefadroxil—Diarrhoea—Fluorouracil—skin cancer	0.000949	0.00174	CcSEcCtD
Cefadroxil—Dermatitis—Temozolomide—skin cancer	0.000948	0.00174	CcSEcCtD
Cefadroxil—Headache—Temozolomide—skin cancer	0.000943	0.00173	CcSEcCtD
Cefadroxil—Dizziness—Fluorouracil—skin cancer	0.000917	0.00169	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000912	0.00168	CcSEcCtD
Cefadroxil—Nausea—Temozolomide—skin cancer	0.000894	0.00164	CcSEcCtD
Cefadroxil—Somnolence—Docetaxel—skin cancer	0.00089	0.00164	CcSEcCtD
Cefadroxil—Vomiting—Fluorouracil—skin cancer	0.000882	0.00162	CcSEcCtD
Cefadroxil—Dyspepsia—Docetaxel—skin cancer	0.000881	0.00162	CcSEcCtD
Cefadroxil—Rash—Fluorouracil—skin cancer	0.000874	0.00161	CcSEcCtD
Cefadroxil—Dermatitis—Fluorouracil—skin cancer	0.000874	0.00161	CcSEcCtD
Cefadroxil—Headache—Fluorouracil—skin cancer	0.000869	0.0016	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Docetaxel—skin cancer	0.000864	0.00159	CcSEcCtD
Cefadroxil—Nausea—Fluorouracil—skin cancer	0.000824	0.00151	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Docetaxel—skin cancer	0.000819	0.0015	CcSEcCtD
Cefadroxil—Body temperature increased—Docetaxel—skin cancer	0.000791	0.00145	CcSEcCtD
Cefadroxil—Abdominal pain—Docetaxel—skin cancer	0.000791	0.00145	CcSEcCtD
Cefadroxil—Hypersensitivity—Docetaxel—skin cancer	0.000737	0.00136	CcSEcCtD
Cefadroxil—Asthenia—Docetaxel—skin cancer	0.000718	0.00132	CcSEcCtD
Cefadroxil—Pruritus—Docetaxel—skin cancer	0.000708	0.0013	CcSEcCtD
Cefadroxil—Diarrhoea—Docetaxel—skin cancer	0.000685	0.00126	CcSEcCtD
Cefadroxil—Dizziness—Docetaxel—skin cancer	0.000662	0.00122	CcSEcCtD
Cefadroxil—Vomiting—Docetaxel—skin cancer	0.000636	0.00117	CcSEcCtD
Cefadroxil—Rash—Docetaxel—skin cancer	0.000631	0.00116	CcSEcCtD
Cefadroxil—Dermatitis—Docetaxel—skin cancer	0.000631	0.00116	CcSEcCtD
Cefadroxil—Headache—Docetaxel—skin cancer	0.000627	0.00115	CcSEcCtD
Cefadroxil—Nausea—Docetaxel—skin cancer	0.000595	0.00109	CcSEcCtD
